amaxa eNews #2 amaxa biosystems
  Issue:
Article:
ContactLegal
Welcome to amaxa eNews #2!
This issue provides you with an overview on the most recent developments in somatic stem cell research and the opportunities Nucleofector Technology offers in this field.

Enjoy reading!
And if you like amaxa eNews recommend it to your friends and colleagues.
Your amaxa team
Hot Topic: Somatic Stem Cells and Nucleofection

Nucleofected Mouse NSC
The ability of stem cells to renew themselves indefinitely and to differentiate into specific tissues holds immense potential for both research into differentiation pathways and for therapeutic use in cell and gene therapy.

       Product Information

Nucleofector Device
Whether you are studying differentiation patterns or you are characterizing the basic metabolic processes of somatic stem cells:

Nucleofector Technology is the ideal tool to bring forward your somatic stem cell research.

       Application Note

OLIG2 Over-expression in Primary Mouse Neural Stem Cells using Nucleofection
Neural stem cells (NSC) - a potential source for remyelinating cell transplants in demyelinating diseases:

The in-vitro differentiation of NSCs into oligodendrocytes.

       Presentation


From mesenchymal to neural stem cells, excellent transfection results can be achieved using the Nucleofector technology. Learn more about

"Nucleofector Technology in Somatic Stem Cell Research"

in this presentation.

       Related FAQs

Our frequently asked questions list contains useful tips and hints as well as background information on the nucleofection of somatic stem cells.

       Related Citations

A large number of citations attest to our Nucleofector Technology being a valuable tool to accelerate your somatic stem cell research.

View List to see a selection of them.
To find even more citations visit our Citations Database.

96-well Shuttle Kits

New!
96-well Shuttle Nucleofector Kit for Human Prostate Epithelial Cells

Coming soon:
Human Bronchial and Mammary Epithelial Cell Kits



Subscribe

Subscribe here to receive future issues of amaxa eNews.
Invite a friend

Recommend amaxa's eNews to a friend or colleague.

Meetings & Shows

See meetings at which amaxa will be present between January and June 2007.
amaxa's Website


Next Issue

amaxa eNews #3
coming in July 2007

Hot Topic: RNAi
You have received this e-mail because you have subscribed to amaxa eNews.
If you do no longer wish to receive amaxa eNews please unsubscribe here or log into your amaxa account to manage your subscriptions.

amaxa's Nucleofection Process, Nucleofector Device and Nucleofector Solutions are covered by PCT Applications PCT/EP01/07348, PCT/DE02/01489, PCT/DE02/01483, and other pending patents, and domestic or foreign applications corresponding thereto.

amaxa, Nucleofector and nucleofection are trademarks of amaxa AG. Other product and company names mentioned herein are the trademarks of their respective owners.

amaxa disclaims all warranties, whether expressed or implied, including any warranty as to the quality, accuracy, safety, or suitability of the information provided in this e-newsletter for any particular purpose. Any use of the information contained on any page of this e-newsletter is evidence of agreement with these terms of use.